DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2017$10,216,000
-29.6%
1,142,744
-30.7%
0.39%
-34.0%
Q4 2016$14,504,000
+30.2%
1,650,0000.0%0.60%
+15.3%
Q3 2016$11,138,000
-62.6%
1,650,000
-80.3%
0.52%
-55.7%
Q2 2016$29,765,000
+5.9%
8,361,069
-12.3%
1.17%
-2.3%
Q1 2016$28,112,000
-23.7%
9,529,361
+9.2%
1.20%
-19.8%
Q4 2015$36,838,000
-17.0%
8,729,361
-10.3%
1.49%
-13.0%
Q3 2015$44,366,000
-35.4%
9,729,361
+2.1%
1.72%
-25.0%
Q2 2015$68,707,000
-21.2%
9,529,361
-19.5%
2.29%
-19.0%
Q1 2015$87,221,000
+55.8%
11,834,5950.0%2.82%
+40.5%
Q4 2014$55,978,000
+28.5%
11,834,595
-3.0%
2.01%
+26.6%
Q3 2014$43,574,000
-21.7%
12,205,6730.0%1.59%
-29.0%
Q2 2014$55,658,000
-3.0%
12,205,6730.0%2.24%
-4.4%
Q1 2014$57,367,000
+1.9%
12,205,673
+8.6%
2.34%
-19.7%
Q4 2013$56,289,000
-14.5%
11,235,406
+6.1%
2.92%
-4.8%
Q3 2013$65,841,000
+33.2%
10,585,406
-2.8%
3.06%
+31.5%
Q2 2013$49,420,00010,885,4062.33%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders